VIMMRIXEQ
LIVE

Serial Number

98294735

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Dec 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VIMMRIXEQ Trademark

Serial Number: 98294735 • Registration: 7606341

VIMMRIXEQ is a trademark filed by GlaxoSmithKline Biologicals SA on December 1, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

December 1, 2023

Registration Date

December 17, 2024

Published for Opposition

October 29, 2024

Goods & Services

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 29, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2024 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 19, 2024 ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 12, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 10, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 29, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 29, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 29, 2024 CNSL
ASSIGNED TO EXAMINER
Jun 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2024 NWOS
NEW APPLICATION ENTERED
Dec 1, 2023 NWAP